C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor

Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2002
11/06/2002	CN1378591A Bacterial protection
11/06/2002	CN1378560A Compounds for treatment of infectious and immune system disorders and method for their use
11/06/2002	CN1378553A Expression of immunogenic hepatitis B surface antigens in transgenic plants
11/06/2002	CN1378552A Novel transcription factor BP1
11/06/2002	CN1377972A Method for preparing L-glutaminic acid
11/06/2002	CN1377971A Composition containing organic nitrogen and its fertilizer containing said composition
11/06/2002	CN1377970A Process for preparing human muscle hemoglobin by gene recombination
11/06/2002	CN1377958A Microbial fermentation agent for treating waste alkohol liquid and its preparing method
11/06/2002	CN1377957A New taxol producing fungus and taxol producing fermentation process
11/06/2002	CN1377956A Ocean bacteria capable of producing haematochrome and method for producing haematochrome using said bacteria
11/06/2002	CN1377955A Fresh edible micro algae composite cultivating source and its use
11/05/2002	US6476213 Cloning and characterization of FLBA gene of H. pylori production of aflagellate
11/05/2002	US6476207 Genes and gene expression products that are differentially regulated in prostate cancer
11/05/2002	US6476195 Secreted protein HNFGF20
11/05/2002	US6476193 NLK1 protein and NLK1 protein complexes
11/05/2002	US6476062 Chemokine receptor antagonists
11/05/2002	US6475997 Methods of stimulating phagocytosis
11/05/2002	US6475785 Single-chain polypeptides comprising troponin I N-terminal fragments and troponin C
11/05/2002	US6475782 Human platelet-derived growth factor receptor
11/05/2002	US6475775 PARG, a GTPase activating protein which interacts with PTPL1
11/05/2002	US6475771 Antimicrobial polypeptides and methods of use
11/05/2002	US6475766 Human osteoclast-derived cathepsin
11/05/2002	US6475765 Subtilisin DY variants having decreased adsorption and increased hydrolysis
11/05/2002	US6475764 Recombinant collagenase type I from clostridium histolyticum and its use for isolating cells and groups of cells
11/05/2002	US6475763 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
11/05/2002	US6475762 Phytase enzymes nucleic acids encoding phytase enzymes and vectors and host cells incorporating same
11/05/2002	US6475761 Glycosyltransferase and DNA encoding the same
11/05/2002	US6475759 Low PH lactic acid fermentation
11/05/2002	US6475758 Generating fatty acid rich oil; mix soap, glyceride and phospholipids, pasteurize, cool, ferment by product, recover fatty acid oil
11/05/2002	US6475753 94 Human Secreted Proteins
11/05/2002	US6475726 Method for identifying validated target and assay combinations for drug development
11/05/2002	US6475724 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
11/05/2002	US6475487 Treatment of a patient by administering an antibody that inhibits cathepsin O
11/05/2002	US6475485 Two novel human cathepsin proteins
11/05/2002	US6475482 Genetically modified tumor-targeted bacteria with reduce virulence
11/05/2002	US6475480 Use of adenoviral E4 reading frames to improve expression of a gene of interest
11/05/2002	US6475387 Microbiological method for eliminating a nitroaromatic compound
11/05/2002	CA2011833C Novel polypeptide and production thereof
11/01/2002	CA2380804A1 Method for producing cytosine nucleosides compounds
10/2002
10/31/2002	WO2002086443A2 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
10/31/2002	WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002	WO2002086154A2 Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages
10/31/2002	WO2002086144A2 Compositions and methods for recombinational cloning of nucleic acid molecules
10/31/2002	WO2002086137A2 Process for the production of l-amino acids by fermentation using coryneform bacteria
10/31/2002	WO2002086136A1 Process for the manufacture of a fermented health-promoting product
10/31/2002	WO2002086135A2 A product removal process for use in a biofermentation system
10/31/2002	WO2002086126A2 Enzymatic method for the enantioselective reduction of keto compounds
10/31/2002	WO2002086123A2 A human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
10/31/2002	WO2002086121A1 Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides
10/31/2002	WO2002086114A1 Lipoxygenase
10/31/2002	WO2002086113A2 Enzyme and snp marker for disease
10/31/2002	WO2002086112A2 Nucleic acid molecules encoding starch degrading enzymes
10/31/2002	WO2002086102A1 Lactic acid bacteria as agents for treating and preventing allergy
10/31/2002	WO2002086099A2 Exopolysaccharide production
10/31/2002	WO2002086097A2 Methods for identifying the target of a compound which inhibits cellular proliferation
10/31/2002	WO2002086094A2 Genes involved in isoprenoid compound production
10/31/2002	WO2002086090A2 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002	WO2002086087A2 Cytokine protein family
10/31/2002	WO2002086085A2 Human timp-1 antibodies
10/31/2002	WO2002086079A2 T1r3 a novel taste receptor
10/31/2002	WO2002086075A2 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs
10/31/2002	WO2002086072A2 Antimicrobial polypeptides and their uses
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002086067A2 Mycobacterial sulfation pathway proteins and methods of use thereof
10/31/2002	WO2002085945A2 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002	WO2002085944A2 Single chain camelid vhh antibodies, method for their production in a mammal and their uses
10/31/2002	WO2002085943A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
10/31/2002	WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	WO2002085936A1 Mutants of green fluorescent protein
10/31/2002	WO2002085935A1 Cell surface layer-binding protein and utilization thereof
10/31/2002	WO2002085930A2 Immunomodulating agents from parasitic worms and method for isolation thereof
10/31/2002	WO2002085923A2 In vivo incorporation of unnatural amino acids
10/31/2002	WO2002085295A2 Methods and compositions for the modulation of biofilm formation
10/31/2002	WO2002085293A2 Production of alpha-lipoic acid
10/31/2002	WO2002070737A8 Compositions and methods relating to osteoarthritis
10/31/2002	WO2002070565A9 High-affinity antagonists of elr-cxc chemokines
10/31/2002	WO2002068585A3 Tip39 polypeptides
10/31/2002	WO2002066650A3 Streptococcus pyogenes polypeptides and corresponding dna fragments
10/31/2002	WO2002064161A9 Method and compositions for immunization with the pseudomonas v antigen
10/31/2002	WO2002061105A9 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
10/31/2002	WO2002057433A9 Homeodomain-interacting protein kinases and the use of the same for influencing cell division and cell proliferation
10/31/2002	WO2002055547A9 Sfrp and peptide motifs that interact with sfrp and methods of their use
10/31/2002	WO2002042455A3 Modifier of organelle metalbolism
10/31/2002	WO2002040652A3 Novel soluble endoproteases for the in vitro processing of recombinant proteins
10/31/2002	WO2002034913A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/31/2002	WO2002033080A3 Regulation of human netrin binding membrane receptor unc5h-1
10/31/2002	WO2002031137A3 Cytomegalovirus intron a fragments
10/31/2002	WO2002029075A3 Multiple inducible gene regulation system
10/31/2002	WO2002024912A3 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
10/31/2002	WO2002018560A3 Butinol i esterase
10/31/2002	WO2002016566A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/31/2002	WO2002014499A3 Claudin polypeptides
10/31/2002	WO2001098343A3 Conserved diaphanous-related formin autoregulatory domain (dad)
10/31/2002	WO2001064898A3 Genes encoding denitrification enzymes
10/31/2002	WO2001061356A9 Her-2 binding antagonists
10/31/2002	WO2001055432A3 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications
10/31/2002	WO2001051633A9 Compositions and methods for the therapy and diagnosis of prostate cancer
10/31/2002	WO2001047962A8 Attenuated microorganisms for the treatment of infection
10/31/2002	US20020162129 Prevention and treatment of alzheimer's disease
10/31/2002	US20020161213 Novel human kinases and polynucleotides encoding the same

1 ... 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 ... 1489